Genotyping of patients treated with selective serotonin reuptake inhibitors.

Vigdis SolhaugTore HaslemoMarianne Kristiansen KringenEspen MoldenErik Sveberg Dietrichs

Published in: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke (2022)

Our findings demonstrate the low prevalence of the most favourable genotype combination for response to SSRIs. Genotype combinations probably contribute to the wide variation between individuals in the efficacy of these drugs and the fact that treatment does not produce the desired outcome in many patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
risk factors
peritoneal dialysis
genome wide
dna methylation